Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.
Identifieur interne : 000110 ( Ncbi/Merge ); précédent : 000109; suivant : 000111Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.
Auteurs : Kenichi A. Tanaka [Géorgie (pays)] ; Katherine Egan ; Fania Szlam ; Satoru Ogawa ; John D. Roback ; Gautam Sreeram ; Robert A. Guyton ; Edward P. ChenSource :
- Transfusion [ 1537-2995 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Annuloplastie de valves cardiaques (effets indésirables), Coagulants (administration et posologie), Coagulants (effets indésirables), Durée du séjour (), Femelle, Fibrinogène (administration et posologie), Fibrinogène (effets indésirables), Humains, Hémorragie postopératoire (), Hémorragie postopératoire (épidémiologie), Hémorragie postopératoire (étiologie), Lyophilisation, Mâle, Sujet âgé, Transfusion de plaquettes (), Transfusion de plaquettes (effets indésirables).
- MESH :
- administration et posologie : Coagulants, Fibrinogène.
- effets indésirables : Annuloplastie de valves cardiaques, Coagulants, Fibrinogène, Transfusion de plaquettes.
- épidémiologie : Hémorragie postopératoire.
- étiologie : Hémorragie postopératoire.
- Adulte, Adulte d'âge moyen, Durée du séjour, Femelle, Humains, Hémorragie postopératoire, Lyophilisation, Mâle, Sujet âgé, Transfusion de plaquettes.
English descriptors
- KwdEn :
- Adult, Aged, Cardiac Valve Annuloplasty (adverse effects), Coagulants (administration & dosage), Coagulants (adverse effects), Female, Fibrinogen (administration & dosage), Fibrinogen (adverse effects), Freeze Drying, Humans, Length of Stay (statistics & numerical data), Male, Middle Aged, Platelet Transfusion (adverse effects), Platelet Transfusion (methods), Postoperative Hemorrhage (epidemiology), Postoperative Hemorrhage (etiology), Postoperative Hemorrhage (therapy).
- MESH :
- chemical , administration & dosage : Coagulants, Fibrinogen.
- adverse effects : Cardiac Valve Annuloplasty, Coagulants, Fibrinogen, Platelet Transfusion.
- epidemiology : Postoperative Hemorrhage.
- etiology : Postoperative Hemorrhage.
- methods : Platelet Transfusion.
- statistics & numerical data : Length of Stay.
- therapy : Postoperative Hemorrhage.
- Adult, Aged, Female, Freeze Drying, Humans, Male, Middle Aged.
Abstract
Platelet (PLT) and plasma transfusion remain the mainstay hemostatic therapy for perioperative bleeding. Several studies have indicated that acquired fibrinogen (FIB) deficiency can be the primary cause of bleeding after cardiac surgery. The aim of this study was to compare hematologic and transfusion profiles between the first-line FIB replacement and PLT transfusion in post-cardiac surgical bleeding.
DOI: 10.1111/trf.12248
PubMed: 23718572
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004549
- to stream PubMed, to step Curation: 004497
- to stream PubMed, to step Checkpoint: 004497
Links to Exploration step
pubmed:23718572Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.</title><author><name sortKey="Tanaka, Kenichi A" sort="Tanaka, Kenichi A" uniqKey="Tanaka K" first="Kenichi A" last="Tanaka">Kenichi A. Tanaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Department of Surgery (Cardiothoracic), Emory University School of Medicine, Atlanta, Georgia.</nlm:affiliation><country xml:lang="fr">Géorgie (pays)</country><wicri:regionArea>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Department of Surgery (Cardiothoracic), Emory University School of Medicine, Atlanta</wicri:regionArea><wicri:noRegion>Atlanta</wicri:noRegion></affiliation></author><author><name sortKey="Egan, Katherine" sort="Egan, Katherine" uniqKey="Egan K" first="Katherine" last="Egan">Katherine Egan</name></author><author><name sortKey="Szlam, Fania" sort="Szlam, Fania" uniqKey="Szlam F" first="Fania" last="Szlam">Fania Szlam</name></author><author><name sortKey="Ogawa, Satoru" sort="Ogawa, Satoru" uniqKey="Ogawa S" first="Satoru" last="Ogawa">Satoru Ogawa</name></author><author><name sortKey="Roback, John D" sort="Roback, John D" uniqKey="Roback J" first="John D" last="Roback">John D. Roback</name></author><author><name sortKey="Sreeram, Gautam" sort="Sreeram, Gautam" uniqKey="Sreeram G" first="Gautam" last="Sreeram">Gautam Sreeram</name></author><author><name sortKey="Guyton, Robert A" sort="Guyton, Robert A" uniqKey="Guyton R" first="Robert A" last="Guyton">Robert A. Guyton</name></author><author><name sortKey="Chen, Edward P" sort="Chen, Edward P" uniqKey="Chen E" first="Edward P" last="Chen">Edward P. Chen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:23718572</idno><idno type="pmid">23718572</idno><idno type="doi">10.1111/trf.12248</idno><idno type="wicri:Area/PubMed/Corpus">004549</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004549</idno><idno type="wicri:Area/PubMed/Curation">004497</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004497</idno><idno type="wicri:Area/PubMed/Checkpoint">004497</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004497</idno><idno type="wicri:Area/Ncbi/Merge">000110</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.</title><author><name sortKey="Tanaka, Kenichi A" sort="Tanaka, Kenichi A" uniqKey="Tanaka K" first="Kenichi A" last="Tanaka">Kenichi A. Tanaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Department of Surgery (Cardiothoracic), Emory University School of Medicine, Atlanta, Georgia.</nlm:affiliation><country xml:lang="fr">Géorgie (pays)</country><wicri:regionArea>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Department of Surgery (Cardiothoracic), Emory University School of Medicine, Atlanta</wicri:regionArea><wicri:noRegion>Atlanta</wicri:noRegion></affiliation></author><author><name sortKey="Egan, Katherine" sort="Egan, Katherine" uniqKey="Egan K" first="Katherine" last="Egan">Katherine Egan</name></author><author><name sortKey="Szlam, Fania" sort="Szlam, Fania" uniqKey="Szlam F" first="Fania" last="Szlam">Fania Szlam</name></author><author><name sortKey="Ogawa, Satoru" sort="Ogawa, Satoru" uniqKey="Ogawa S" first="Satoru" last="Ogawa">Satoru Ogawa</name></author><author><name sortKey="Roback, John D" sort="Roback, John D" uniqKey="Roback J" first="John D" last="Roback">John D. Roback</name></author><author><name sortKey="Sreeram, Gautam" sort="Sreeram, Gautam" uniqKey="Sreeram G" first="Gautam" last="Sreeram">Gautam Sreeram</name></author><author><name sortKey="Guyton, Robert A" sort="Guyton, Robert A" uniqKey="Guyton R" first="Robert A" last="Guyton">Robert A. Guyton</name></author><author><name sortKey="Chen, Edward P" sort="Chen, Edward P" uniqKey="Chen E" first="Edward P" last="Chen">Edward P. Chen</name></author></analytic><series><title level="j">Transfusion</title><idno type="eISSN">1537-2995</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cardiac Valve Annuloplasty (adverse effects)</term><term>Coagulants (administration & dosage)</term><term>Coagulants (adverse effects)</term><term>Female</term><term>Fibrinogen (administration & dosage)</term><term>Fibrinogen (adverse effects)</term><term>Freeze Drying</term><term>Humans</term><term>Length of Stay (statistics & numerical data)</term><term>Male</term><term>Middle Aged</term><term>Platelet Transfusion (adverse effects)</term><term>Platelet Transfusion (methods)</term><term>Postoperative Hemorrhage (epidemiology)</term><term>Postoperative Hemorrhage (etiology)</term><term>Postoperative Hemorrhage (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Annuloplastie de valves cardiaques (effets indésirables)</term><term>Coagulants (administration et posologie)</term><term>Coagulants (effets indésirables)</term><term>Durée du séjour ()</term><term>Femelle</term><term>Fibrinogène (administration et posologie)</term><term>Fibrinogène (effets indésirables)</term><term>Humains</term><term>Hémorragie postopératoire ()</term><term>Hémorragie postopératoire (épidémiologie)</term><term>Hémorragie postopératoire (étiologie)</term><term>Lyophilisation</term><term>Mâle</term><term>Sujet âgé</term><term>Transfusion de plaquettes ()</term><term>Transfusion de plaquettes (effets indésirables)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Coagulants</term><term>Fibrinogen</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Coagulants</term><term>Fibrinogène</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Cardiac Valve Annuloplasty</term><term>Coagulants</term><term>Fibrinogen</term><term>Platelet Transfusion</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Annuloplastie de valves cardiaques</term><term>Coagulants</term><term>Fibrinogène</term><term>Transfusion de plaquettes</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Postoperative Hemorrhage</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Postoperative Hemorrhage</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Platelet Transfusion</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Length of Stay</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Postoperative Hemorrhage</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Hémorragie postopératoire</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hémorragie postopératoire</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Freeze Drying</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Durée du séjour</term><term>Femelle</term><term>Humains</term><term>Hémorragie postopératoire</term><term>Lyophilisation</term><term>Mâle</term><term>Sujet âgé</term><term>Transfusion de plaquettes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Platelet (PLT) and plasma transfusion remain the mainstay hemostatic therapy for perioperative bleeding. Several studies have indicated that acquired fibrinogen (FIB) deficiency can be the primary cause of bleeding after cardiac surgery. The aim of this study was to compare hematologic and transfusion profiles between the first-line FIB replacement and PLT transfusion in post-cardiac surgical bleeding.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23718572</PMID><DateCreated><Year>2014</Year><Month>01</Month><Day>10</Day></DateCreated><DateCompleted><Year>2014</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2014</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.</ArticleTitle><Pagination><MedlinePgn>109-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.12248</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Platelet (PLT) and plasma transfusion remain the mainstay hemostatic therapy for perioperative bleeding. Several studies have indicated that acquired fibrinogen (FIB) deficiency can be the primary cause of bleeding after cardiac surgery. The aim of this study was to compare hematologic and transfusion profiles between the first-line FIB replacement and PLT transfusion in post-cardiac surgical bleeding.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">In this prospective, randomized, open-label study, 20 adult patients who underwent valve replacement or repair and fulfilled preset visual bleeding scale were randomized to 4 g of FIB or 1 unit of apheresis PLTs. Primary endpoints included hemostatic condition in the surgical field and 24-hour hemostatic product usage. Hematologic data, clinical outcome, and safety data were collected up to the 28th day postoperative visit.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In patients who received the first-line FIB concentrate (n = 10), the visual bleeding scale improved after intervention, and the incidence of PLT transfusion and total plasma donor exposure were lower compared to the PLT group (n = 10). Postintervention FIB level was statistically higher (209 mg/dL vs. 165 mg/dL) in the FIB group than in the PLT group, but PLT count and prothrombin were lower. There were no statistical differences in the postoperative blood loss and red blood cell transfusion between two groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our preliminary data indicate that the primary FIB replacement may potentially reduce the incidence of PLT transfusion and the number of donor exposures. Plasma FIB level of 200 mg/dL is attainable with a single dose of 4 g, and this level seems to mitigate bleeding despite moderately decreased thrombin generation.</AbstractText><CopyrightInformation>© 2013 American Association of Blood Banks.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kenichi A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia; Department of Surgery (Cardiothoracic), Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egan</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Szlam</LastName><ForeName>Fania</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Satoru</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Roback</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Sreeram</LastName><ForeName>Gautam</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Guyton</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Edward P</ForeName><Initials>EP</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01283321</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003029">Coagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-32-5</RegistryNumber><NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058385" MajorTopicYN="N">Cardiac Valve Annuloplasty</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003029" MajorTopicYN="N">Coagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005612" MajorTopicYN="N">Freeze Drying</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="N">Platelet Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>04</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23718572</ArticleId><ArticleId IdType="doi">10.1111/trf.12248</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Géorgie (pays)</li></country></list><tree><noCountry><name sortKey="Chen, Edward P" sort="Chen, Edward P" uniqKey="Chen E" first="Edward P" last="Chen">Edward P. Chen</name><name sortKey="Egan, Katherine" sort="Egan, Katherine" uniqKey="Egan K" first="Katherine" last="Egan">Katherine Egan</name><name sortKey="Guyton, Robert A" sort="Guyton, Robert A" uniqKey="Guyton R" first="Robert A" last="Guyton">Robert A. Guyton</name><name sortKey="Ogawa, Satoru" sort="Ogawa, Satoru" uniqKey="Ogawa S" first="Satoru" last="Ogawa">Satoru Ogawa</name><name sortKey="Roback, John D" sort="Roback, John D" uniqKey="Roback J" first="John D" last="Roback">John D. Roback</name><name sortKey="Sreeram, Gautam" sort="Sreeram, Gautam" uniqKey="Sreeram G" first="Gautam" last="Sreeram">Gautam Sreeram</name><name sortKey="Szlam, Fania" sort="Szlam, Fania" uniqKey="Szlam F" first="Fania" last="Szlam">Fania Szlam</name></noCountry><country name="Géorgie (pays)"><noRegion><name sortKey="Tanaka, Kenichi A" sort="Tanaka, Kenichi A" uniqKey="Tanaka K" first="Kenichi A" last="Tanaka">Kenichi A. Tanaka</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000110 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000110 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:23718572
|texte= Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:23718572" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |